Acasti Pharma Inc (ACST)
3.44
+0.04
(+1.18%)
USD |
NASDAQ |
Mar 28, 16:00
3.44
0.00 (0.00%)
After-Hours: 18:06
Acasti Pharma Max Drawdown (5Y): 98.73% for Feb. 29, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
February 29, 2024 | 98.73% |
January 31, 2024 | 98.73% |
December 31, 2023 | 98.73% |
November 30, 2023 | 98.73% |
October 31, 2023 | 98.73% |
September 30, 2023 | 98.73% |
August 31, 2023 | 98.55% |
July 31, 2023 | 98.52% |
June 30, 2023 | 98.52% |
May 31, 2023 | 98.52% |
April 30, 2023 | 98.52% |
March 31, 2023 | 98.52% |
February 28, 2023 | 98.52% |
January 31, 2023 | 98.52% |
December 31, 2022 | 98.52% |
November 30, 2022 | 98.45% |
October 31, 2022 | 98.45% |
September 30, 2022 | 98.45% |
August 31, 2022 | 98.45% |
July 31, 2022 | 98.45% |
June 30, 2022 | 98.45% |
May 31, 2022 | 98.45% |
April 30, 2022 | 98.45% |
March 31, 2022 | 98.45% |
February 28, 2022 | 98.45% |
Date | Value |
---|---|
January 31, 2022 | 98.45% |
December 31, 2021 | 98.45% |
November 30, 2021 | 98.45% |
October 31, 2021 | 98.45% |
September 30, 2021 | 98.45% |
August 31, 2021 | 98.45% |
July 31, 2021 | 98.45% |
June 30, 2021 | 98.45% |
May 31, 2021 | 98.45% |
April 30, 2021 | 98.45% |
March 31, 2021 | 98.45% |
February 28, 2021 | 98.45% |
January 31, 2021 | 98.45% |
December 31, 2020 | 98.45% |
November 30, 2020 | 98.45% |
October 31, 2020 | 98.45% |
September 30, 2020 | 98.45% |
August 31, 2020 | 98.45% |
July 31, 2020 | 98.45% |
June 30, 2020 | 98.45% |
May 31, 2020 | 98.45% |
April 30, 2020 | 98.45% |
March 31, 2020 | 98.45% |
February 29, 2020 | 98.45% |
January 31, 2020 | 98.45% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
98.45%
Minimum
Mar 2019
98.73%
Maximum
Sep 2023
98.49%
Average
98.45%
Median
Mar 2019
Max Drawdown (5Y) Benchmarks
Aurinia Pharmaceuticals Inc | 87.58% |
Edesa Biotech Inc | 99.60% |
Lexaria Bioscience Corp | 98.90% |
Xenon Pharmaceuticals Inc | 64.74% |
ESSA Pharma Inc | 99.40% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -63.19 |
Beta (5Y) | 1.485 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 123.2% |
Historical Sharpe Ratio (5Y) | -0.3585 |
Historical Sortino (5Y) | -0.7504 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 42.47% |